Self-funded private treatment has grown strongly since 2020, driven by NHS waits — 7.3 million treatments in the queue, median 12.4 weeks. The big sellers are hips (£12,000–£15,500), knees, cataracts (£2,000–£4,000 per eye) and diagnostics, paid from savings, loans and fixed-price packages. Insurance can't cover the wait you're already on — only the next one.
- ✓Self-pay private treatment has grown strongly since 2020, tracking NHS waits.
- ✓Top sellers: hip and knee replacements, cataracts, MRI and other diagnostics.
- ✓Insurance can't cover an existing wait — self-pay now, insure for next time.
The boom, briefly
Before 2020, paying privately for an operation without insurance was a niche pursuit, largely confined to the well-off and the desperate. Since then it has become one of the best-documented shifts in UK healthcare: industry data from the Private Healthcare Information Network (PHIN) and private hospital groups has shown self-pay admissions running well above pre-pandemic levels year after year, even as the initial post-COVID spike settled. The driver isn't mysterious. With 7.3 million treatments on the NHS list, a median wait of 12.4 weeks and 1 in 12 waiting 38.6 weeks or more, a meaningful number of people have decided that time is the thing worth buying.
It's a different customer than private healthcare's stereotype: often first-time private patients, often retired or mid-career, spending savings on one specific fix rather than buying into a private system wholesale. Hospital groups have noticed, and the product has reshaped itself around them — transparent price lists, fixed-price packages and finance desks are now standard where a decade ago you'd have needed a consultant's secretary and a strong nerve to get a number at all.
What people actually buy
Self-pay demand concentrates where NHS waits are longest and the improvement in daily life is biggest — which in practice means orthopaedics, eyes and diagnostics. The recurring purchases, at published price-list rates:
| Treatment | Typical self-pay price |
|---|---|
| Hip replacement | £12,000–£15,500 |
| Knee replacement | £13,000–£16,000 |
| Cataract surgery | £2,000–£4,000 per eye |
| Inguinal hernia repair | £2,500–£4,500 |
| MRI scan | £300–£500 |
| Initial consultation | £150–£300 |
The pattern maps almost perfectly onto the waiting list: trauma & orthopaedics carries a 14.1-week median with a 1-in-12 tail past 41.8 weeks, and diagnostics have their own queue — around 1 in 4 people wait six-plus weeks for tests. Diagnostics are also the boom's quiet engine: a £300–£500 MRI is an affordable way to buy certainty, and it's often the first private purchase someone ever makes.
How people are paying
Savings remain the main source — these are exactly the sums people hold for emergencies, and a hip that hurts every day qualifies as one in most households' accounting. Around that core, the financing landscape has matured: most private hospital groups now offer medical loans through consumer-credit partners, typically spreading a five-figure operation over several years, and fixed-price packages have become the norm, bundling surgeon, anaesthetist, hospital stay and routine aftercare into one quoted number. Some families contribute jointly to a parent's operation; some borrow against pension lump sums.
Sorting this one — covering the next?
The honest place insurance fits
Here's the part a comparison site should say plainly: if you're already on a waiting list, health insurance is not the answer to this wait. Policies exclude pre-existing conditions, so the hip that's already painful won't be covered — self-pay is the realistic private route for it. Where insurance earns its place is the next thing: for roughly £80 a month for an average adult, it means the next diagnosis starts with a consultation in days rather than a 12-week median and a five-figure decision. Many self-payers reach exactly that conclusion after writing one large cheque — pay for this one, insure against the sequel. Both halves of that logic are sound, and neither should be rushed: our guides cover the pre-existing rules in full, so you know exactly what a new policy would and wouldn't pick up before you buy anything.
Frequently asked questions
What is driving Britain's self-pay boom?
NHS waiting times, overwhelmingly. With 7.3 million treatments queued, a 12.4-week median and 1 in 12 waiting over 38.6 weeks, people — often first-time private patients — are spending savings to buy time. Industry data from PHIN and hospital groups has shown self-pay volumes running well above pre-2020 levels throughout the decade.
What do self-pay patients buy most in the boom?
The list maps onto the longest NHS queues: hip replacements (£12,000–£15,500), knee replacements (£13,000–£16,000), cataract surgery (£2,000–£4,000 per eye) and hernia repairs, plus a large volume of diagnostics — a £300–£500 MRI is often someone's first private purchase, buying certainty rather than treatment.
How do people afford self-pay private surgery?
Savings first — these are the sums people keep for emergencies. Beyond that, most hospital groups offer medical loans spreading five-figure costs over years, and fixed-price packages bundle surgeon, anaesthetist, stay and routine aftercare into one quote. Interest and package small print can add real cost, so both need reading carefully.
Can I buy health insurance instead of self-paying for my current wait?
No — and any honest comparison site should say so. Insurance excludes pre-existing conditions, so a problem you already have won't be covered by a new policy. Self-pay is the realistic private route for an existing wait; insurance (~£80/month average adult) is protection for the next diagnosis, not this one.
Is the self-pay boom likely to continue?
The conditions behind it — a 7.3 million waiting list, long surgical medians, matured financing options — remain in place in 2026, so self-pay demand looks structural rather than a post-pandemic blip. If NHS waits shortened substantially, the calculus would change; the monthly RTT data is the thing to watch.